The PLOS ONE Editors retract this article [1] because it was identified as one of a series of submissions for which we have concerns about authorship, competing interests, and peer review. We regret that the issues were not addressed prior to the article’s publication.
ABG and MAA did not agree with the retraction. JL and ME responded but expressed neither agreement nor disagreement with the editorial decision. RMA and SMA either did not respond directly or could not be reached.
Reference
- 1. Gurung AB, Ali MA, Lee J, El-Zaidy M, Aljowaie RM, Almutairi SM (2022) Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19. PLoS ONE 17(6): e0268919. https://doi.org/10.1371/journal.pone.0268919 pmid:35657783
Citation: The PLOS ONE Editors (2022) Retraction: Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19. PLoS ONE 17(8): e0273489. https://doi.org/10.1371/journal.pone.0273489
Published: August 31, 2022
Copyright: © 2022 The PLOS ONE Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.